oleanolic acid has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarcón-Aguilar, FJ; Almanza-Pérez, JC; Aquino-Jarquín, G; Estrada-Soto, S; Fortis-Barrera, Á; Giacoman-Martínez, A; Huang, F; Loza-Rodríguez, H | 1 |
| Maurya, R; Puri, A; Rajendran, SM; Shah, P; Siddiqi, MI; Srivastava, A; Yadav, PP | 1 |
2 other study(ies) available for oleanolic acid and Dyslipidemia
| Article | Year |
|---|---|
Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Diabetes Mellitus, Type 2; Dyslipidemias; Gene Expression Regulation; Glucose Transporter Type 4; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Mice; Myoblasts, Skeletal; Oleanolic Acid; PPAR alpha; PPAR gamma; Protein Transport; Signal Transduction | 2020 |
β-Amyrin acetate and β-amyrin palmitate as antidyslipidemic agents from Wrightia tomentosa leaves.
Topics: Animals; Apocynaceae; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dyslipidemias; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Mesocricetus; Models, Molecular; Molecular Structure; Oleanolic Acid; Plant Leaves; Plants, Medicinal | 2012 |